Skip to the main content.

Clinical Trial Therapeutic Monitoring

Customized to the product and clinical indication

Clinical Trial Therapeutic Monitoring

Customized Programs Tailored to the Product and Clinical Indication


At KBI Biopharma, we are at the forefront of the rapidly-evolving field of cell therapy, providing a wide range of cutting-edge services to support the development and commercialization of next-generation cell-based treatments.

At KBI our therapeutic monitoring programs are custom-tailored to the product & clinical indication leveraging multiple methods.

Aims of a program:

Safety, Acute Affects

  • Product engraftment, persistence
  • Product-related immunological response (cellular, soluble factors)


  • To identify marker(s) that predict a patient’s response to therapy
  • To identify cell type(s) that are responsible for therapeutic success

For example, methods may include:

  • In vitro cellular bioassays (anti-tumor cytotoxicity, product differentiation, expansion, tumor site accumulation)
  • Multi-color Flow cytometric analysis (surface, intracellular, cell signaling)
  • Cytokine analysis via ELISA, ELISPOT, or Bead-Based Multi-cytokine array
  • Cell activation, Cell cycle monitoring, Proliferation, Apoptosis

Explore More Cell Therapy:

Ready to Learn More? Get in Touch with our Team.


Contact Us

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.